연구동향 분석
박사

A형 인플루엔자 H7N9바이러스의 항원을 발현하는 백신 후보균주의 면역학적 효능과 방어효능 검증

김제형 2018년

논문상세정보
인용/피인용
' A형 인플루엔자 H7N9바이러스의 항원을 발현하는 백신 후보균주의 면역학적 효능과 방어효능 검증' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Brown nick chicken
  • Cell mediated immunity
  • H7N9 조류 인플루엔자 바이러스
  • Humoral immunity
  • Influenza/A H7N9 virus
  • Protection
  • Salmonella Typhimurium
  • apc
  • pbmc
  • vaccine
  • 뉴라미니다아제
  • 막 단백질
  • 백신
  • 산란계
  • 살모넬라
  • 세포성 면역
  • 수지상세포
  • 체액성 면역
  • 항원
  • 항원제시세포
  • 헤마글루티닌
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
467 0

0.0%

' A형 인플루엔자 H7N9바이러스의 항원을 발현하는 백신 후보균주의 면역학적 효능과 방어효능 검증' 의 참고문헌

  • den Haan, Joke M.M.; Arens, Ramon; Zelm, Menno C. van. "The activation of the adaptive immune system: Cross-talk between antigen-presenting cells, T cells and B cells". Immunology Letters. 162 (2): 103–112. doi:10.1016/j.imlet.2014.10.011.
  • Zenglin Pei, Xiaohong Jiang, Zhu Yang, XR, et al. Oral Delivery of a Novel Attenuated Salmonella Vaccine Expressing Influenza A Virus Proteins Protects Mice against H5N1 and H1N1 Viral Infection. Available at: http://journals.plos.org/plosone/article/asset?id=10.1371/journal.pone.0129276.PDF.
  • Yiu Lai K, Wing Yiu Ng G, Fai Wong K, et al (2013) Human H7N9 avian influenza virus infection: a review and pandemic risk assessment. Emerg Microbes Infect 2:e48. doi: 10.1038/emi.2013.48
  • Yiu Lai K, Wing Yiu Ng G, Fai Wong K, Fan Ngai Hung I, Kam Fai Hong J, Fan Cheng F, Kwok Cheung Chan J. 2013. Human H7N9 avian influenza virus infection: a review and pandemic risk assessment. Emerg Microbes Infect 2:e48.
  • Won G, Hajam IA, Lee JH. Improved lysis efficiency and immunogenicity of Salmonella ghosts mediated by co-expression of λ phage holin-endolysin and ɸ X174 gene E. Nat Publ Gr 2017:1–12. doi:10.1038/srep45139.
  • Wang X, Chan CC, Yang M, et al (2011) A critical role of IL-17 in modulating the B-cell response during H5N1 influenza virus infection. Cell Mol Immunol 8:462–468. doi: 10.1038/cmi.2011.38
  • Venema K. The Impact of Food Bioactives on Health. 2015. doi:10.1007/978-3- 319-16104-4.
  • Treanor JJ, et al. (2001) Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans. Vaccine 19(13–14):1732–7.
  • Tang LH, Lim JH, Kuah LF, Lau YF (2014) Complete protection against lethal challenge of novel H7N9 virus with heterologous inactivated H7 vaccine in mice. Vaccine 32:5375–5378. doi: 10.1016/j.vaccine.2014.07.087
  • Sharpe AH (2009) Mechanisms of costimulation. Immunol Rev 229:5–11. doi: 10.1111/j.1600-065X.2009.00784.x
  • Shadbolt BP (2017) WHO : H7N9 virus a€TM one of the most lethal so far’.9–12.
  • Seo SH, Webster RG (2001) Cross-reactive, cell-mediated immunity and protection of chickens from lethal H5N1 influenza virus infection in Hong Kong poultry markets. J Virol 75:2516–25. doi: 10.1128/JVI.75.6.2516-2525.2001
  • Schotsaert M, Ysenbaert T, Smet A, et al (2016) Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategies. Sci Rep 6:24402. doi: 10.1038/srep24402
  • Rohm C, Horimoto T, Kawaoka Y, et al (1995) Do hemagglutinin genes of highly pathogenic avian influenza viruses constitute unique phylogenetic lineages? Virology 209:664–70. doi: 10.1006/viro.1995.1301
  • Rohm C, Horimoto T, Kawaoka Y, Suss J, Webster RG. 1995. Do hemagglutinin genes of highly pathogenic avian influenza viruses constitute unique phylogenetic lineages? Virology 209:664–70.
  • Pejoski D, Zeng W, Rockman S, et al (2010) A lipopeptide based on the M2 and HA proteins of influenza A viruses induces protective antibody. Immunol Cell Biol 88:605–611. doi: 10.1038/icb.2010.15
  • Peiris M, et al. (1999) Human infection with influenza H9N2. Lancet (London, England) 354(9182):916–7.
  • Pei Z, Jiang X, Yang Z, et al (2015) Oral delivery of a novel attenuated salmonella vaccine expressing influenza a virus proteins protects mice against H5N1 and H1N1 viral infection. PLoS One 10:e0129276. doi: 10.1371/journal.pone.0129276
  • Pan Z, et al. (2010) Prime-boost immunization using a DNA vaccine delivered by attenuated Salmonella enterica serovar typhimurium and a killed vaccine completely protects chickens from H5N1 highly pathogenic avian influenza virus. Clinical and vaccine immunology : CVI 17(4):518–23.
  • Nicholson KG, Wood JM, Zambon M. 2003. Influenza. Lancet (London, England) 362:1733–45.
  • Nicholson KG, Wood JM, Zambon M (2003) Influenza. Lancet (London, England) 362:1733–45. doi: 10.1016/S0140-6736(03)14854-4
  • Mittal, Sharad K; Roche, Paul A. "Suppression of antigen presentation by IL-10". Current Opinion in Immunology. 34: 22–27. doi:10.1016/j.coi.2014.12.009. PMC 4444374 Freely accessible. PMID 25597442.
  • Mills KHG (2008) Induction, function and regulation of IL-17-producing T cells. Eur J Immunol 38:2636–2649. doi: 10.1002/eji.200838535
  • Mbongue, Jacques; Nicholas, Dequina; Firek, Anthony; Langridge, William (2014-04-30). "The Role of Dendritic Cells in Tissue-Specific Autoimmunity". Journal of Immunology Research. 2014: 1–17. doi:10.1155/2014/857143. PMC 4022068 Freely accessible. PMID 24877157.
  • Matteoli G, Fahl E, Warnke P, et al (2008) Role of IFN-gamma and IL-6 in a protective immune response to Yersinia enterocolitica in mice. BMC Microbiol 8:153. doi: 10.1186/1471-2180-8-153
  • Mastroeni P1, Chabalgoity JA, Dunstan SJ, Maskell DJ, Dougan G. Salmonella: immune responses and vaccines. Vet J. 2001 Mar;161(2):132-64.
  • Martin Petric, Lorraine Comanor and CAP (2006) Role of the Laboratory in Diagnosis of Influenza during Seasonal Epidemics and Potential Pandemics.
  • Li Q, Zhou L, Zhou M, et al (2014) Epidemiology of Human Infections with Avian Influenza A(H7N9) Virus in China. N Engl J Med 370:520–532. doi: 10.1056/NEJMoa1304617
  • Lee C-W, Senne DA, Suarez DL (2006) Development and application of reference antisera against 15 hemagglutinin subtypes of influenza virus by DNA vaccination of chickens. Clinical and vaccine immunology : CVI 13(3):395–402.
  • Layton SL, Kapczynski DR, Higgins S, et al (2009) Vaccination of chickens with recombinant Salmonella expressing M2e and CD154 epitopes increases protection and decreases viral shedding after low pathogenic avian influenza challenge. Poult Sci 88:2244–2252. doi: 10.3382/ps.2009-00251
  • Laddy DJ, et al. (2007) Immunogenicity of novel consensus-based DNA vaccines against avian influenza. Vaccine 25:2984–2989
  • Laddy DJ, et al. (2007) Immunogenicity of novel consensus-based DNA vaccines against avian influenza. Vaccine 25(16):2984–9.
  • Kambayashi, Taku; Laufer, Terri M. "Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell?". Nature Reviews Immunology. 14 (11): 719–730. doi:10.1038/nri3754.
  • Kalthoff D, Globig A, Beer M. 2010. (Highly pathogenic) avian influenza as a zoonotic agent. Vet Microbiol 140:237– 45.
  • Kalthoff D, Globig A, Beer M (2010) (Highly pathogenic) avian influenza as a zoonotic agent. Vet Microbiol 140:237– 45. doi: 10.1016/j.vetmic.2009.08.022
  • Jump up to: a b Brzostek, Joanna; Gascoigne, Nicholas R. J.; Rybakin, Vasily (2016-01-01). "Cell Type-Specific Regulation of Immunological Synapse Dynamics by B7 Ligand Recognition". T Cell Biology. 7: 24. doi:10.3389/fimmu.2016.00024. PMC 4740375 Freely accessible. PMID 26870040.
  • Jin W, Dong C (2013) IL-17 cytokines in immunity and inflammation. Emerg Microbes Infect 2:e60. doi: 10.1038/emi.2013.58
  • Je Hyoung K, Ahmed Hajam I, Hwa Lee J. A consensus-hemagglutinin- based vaccine delivered by an attenuated Salmonella mutant protects chickens against heterologous H7N1 influenza virus. Oncotarget 2017. doi:10.18632/oncotarget.16353.
  • Je Hyoung K, Ahmed Hajam I, Hwa Lee J (2017) A consensus-hemagglutinin-based vaccine delivered by an attenuated Salmonella mutant protects chickens against heterologous H7N1 influenza virus. Oncotarget. doi: 10.18632/oncotarget.16353
  • Hur J, Lee JH. 2011. Enhancement of immune responses by an attenuated Salmonella enterica serovar Typhimurium strain secreting an Escherichia coli heat-labile enterotoxin B subunit protein as an adjuvant for a live Salmonella vaccine candidate. Clin Vaccine Immunol 18:203–9.
  • Hur J, Lee JH (2011) Enhancement of immune responses by an attenuated Salmonella enterica serovar Typhimurium strain secreting an Escherichia coli heat-labile enterotoxin B subunit protein as an adjuvant for a live Salmonella vaccine candidate. Clin Vaccine Immunol 18:203–9. doi: 10.1128/CVI.00407-10
  • Hopkins S, Kraehenbuhl JP, Sch del F, et al (1995) A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization. Infect Immun 63:3279–86.
  • Hoelscher MA, et al. (2006) Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice. Lancet (London, England) 367(9509):475–81.
  • Hirabayashi Y, Kurata H, Funato H, et al (1990) Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination. Vaccine 8:243–8.
  • Harding, Clifford V.; Boom, W. Henry. "Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors". Nature Reviews Microbiology. 8 (4): 296–307. doi:10.1038/nrmicro2321. PMC 3037727 Freely accessible. PMID 20234378.
  • Hamada H, Garcia-Hernandez M d. l. L, Reome JB, et al (2009) Tc17, a Unique Subset of CD8 T Cells That Can Protect against Lethal Influenza Challenge. J Immunol 182:3469–3481. doi: 10.4049/jimmunol.0801814
  • Hamada H, Garcia-Hernandez M d. l. L, Reome JB, Misra SK, Strutt TM, McKinstry KK, Cooper AM, Swain SL, Dutton RW. 2009. Tc17, a Unique Subset of CD8 T Cells That Can Protect against Lethal Influenza Challenge. J Immunol 182:3469–3481.
  • Hajam IA, Lee JH (2017) Preexisting Salmonella -specific immunity interferes with the subsequent development of immune responses against the Salmonella strains delivering H9N2 hemagglutinin. Vet Microbiol 205:117–123. doi: 10.1016/j.vetmic.2017.05.021
  • Hajam IA, Lee JH (2017) An Influenza HA and M2e Based Vaccine Delivered by a Novel Attenuated Salmonella Mutant Protects Mice against Homologous H1N1 Infection. Front Microbiol 8:872. doi: 10.3389/fmicb.2017.00872
  • Gong Z, Lv H, Ding H, et al (2014) Epidemiology of the avian influenza A (H7N9) outbreak in Zhejiang Province, China. BMC Infect Dis 14:244. doi: 10.1186/1471-2334-14-244
  • Gong Z, Lv H, Ding H, Han J, Sun J, Chai C, Cai J, Yu Z, Chen E. 2014. Epidemiology of the avian influenza A (H7N9) outbreak in Zhejiang Province, China. BMC Infect Dis 14:244.
  • Goldblum RM (1990) The role of IgA in local immune protection. J Clin Immunol 10:64S–70S; discussion 70S–71S.
  • Ghendon Y1.The immune response to influenza vaccines.Acta Virol. 1990 May;34(3):295-304.
  • Gaschen B, et al. (2002) Diversity considerations in HIV-1 vaccine selection. Science 296:2354–2360.
  • Gao R, Cao B, Hu Y, et al (2013) Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus. N Engl J Med 368:1888–1897. doi: 10.1056/NEJMoa1304459
  • Gao F, et al. (2003) Consensus and ancestral state HIV vaccines. Science 299:1517–1518.
  • G. Nagarajan, P. Ravikumar, C. Ashok Kumar, G.R. Reddy, H.J. Dechamma, V.V.S. Suryanarayana Self replicating gene vaccine carrying P1-2A gene of FMDV serotype O and its effects on the immune responses of cattle Ind J Virol, 22 (1) (2011), pp. 50-58
  • Franca MS, Brown JD. 2014. Influenza pathobiology and pathogenesis in avian species. Curr Top Microbiol Immunol 385:221–42.
  • Franca MS, Brown JD (2014) Influenza pathobiology and pathogenesis in avian species. Curr Top Microbiol Immunol 385:221–42. doi: 10.1007/82_2014_385
  • Fouchier RAM, et al. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome.
  • Ehrlich HJ, et al. (2008) A clinical trial of a whole-virus H5N1 vaccine derived from cell culture. N Engl J Med 359:2573–2584
  • Ehrlich HJ, et al. (2008) A Clinical Trial of a Whole-Virus H5N1 Vaccine Derived from Cell Culture. New England Journal of Medicine 358(24):2573–2584.
  • Ebensen T, Paukner S, Link C, et al (2004) Bacterial ghosts are an efficient delivery system for DNA vaccines. J Immunol 172:6858–65.
  • Deng L, Cho KJ, Fiers W, Saelens X (2015) M2e-Based Universal Influenza A Vaccines. Vaccines 3:105–36. doi: 10.3390/vaccines3010105
  • Cox RJ, Madhun AS, Hauge S, et al (2009) A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine. Vaccine 27:1889–1897. doi: 10.1016/j.vaccine.2009.01.116
  • Couch RB, Patel SM, Wade-Bowers CL, Ni o D (2012) A Randomized Clinical Trial of an Inactivated Avian Influenza A (H7N7) Vaccine. PLoS One 7:e49704. doi: 10.1371/journal.pone.0049704
  • Corth sy B (2013) Multi-faceted functions of secretory IgA at mucosal surfaces. Front Immunol 4:185. doi: 10.3389/fimmu.2013.00185
  • Chen M-W, Cheng T-JR, Huang Y, et al (2008) A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses. Proc Natl Acad Sci U S A 105:13538–43. doi: 10.1073/pnas.0806901105
  • Chen M-W, Cheng T-JR, Huang Y, Jan J-T, Ma S-H, Yu AL, et al. A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses. Proc Natl Acad Sci U S A 2008;105:13538–43. doi:10.1073/ pnas.0806901105.
  • Chen M-W, Cheng T-JR, Huang Y, Jan J-T, Ma S-H, Yu AL, Wong C-H, Ho DD. 2008. A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses. Proc Natl Acad Sci U S A 105:13538–43.
  • Bresson J-L, et al. (2006) Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial. Lancet (London, England) 367(9523):1657–64.
  • Berlanda Scorza F, Tsvetnitsky V, Donnelly JJ. 2016. Universal influenza vaccines: Shifting to better vaccines. Vaccine 34:2926–2933.
  • Berlanda Scorza F, Tsvetnitsky V, Donnelly JJ (2016) Universal influenza vaccines: Shifting to better vaccines. Vaccine 34:2926–2933. doi: 10.1016/j.vaccine.2016.03.085
  • Belser JA, Zeng H, Katz JM, Tumpey TM (2011) Infection with highly pathogenic H7 influenza viruses results in an attenuated proinflammatory cytokine and chemokine response early after infection. The Journal of infectious diseases 203(1):40–8.
  • Bantia S, Ghate AA, Ananth SL, et al (1998) Generation and characterization of a mutant of influenza A virus selected with the neuraminidase inhibitor BCX-140. Antimicrob Agents Chemother 42:801–7.
  • Abdelwhab EM, Veits J, Mettenleiter TC, Lang G, Gagnon A, Geraci JR, Kwon TY, Lee SS, Kim CY, Shin JY, Koopmans M. 2014. Prevalence and control of H7 avian influenza viruses in birds and humans. Epidemiol Infect 142:896–920.
  • ABDELWHAB EM, VEITS J, METTENLEITER TC, et al (2014) Prevalence and control of H7 avian influenza viruses in birds and humans. Epidemiol Infect 142:896–920. doi: 10.1017/S0950268813003324